You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR OXYTETRACYCLINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for oxytetracycline

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00570648 ↗ A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization Completed University of Virginia N/A 2007-06-01 Hypothesis: 1% sodium hyaluronate (Healon), applied at end of surgery to the surface of a corneal transplant will not shorten graft reepithelialization time when compared to coating with nothing. We also wish to measure and compare visual acuity in this immediate post operative period. We also wish to assess the safety of using this agent on the epithelium post-operatively. We will recruit 50 high risk patients (see inclusion criteria) here at the University of Virginia to randomly receive nothing or sodium hyaluronate (Healon) on the ocular surface at the end of surgery, and follow time to reepithelialization of the corneal transplant grafts.
NCT01032499 ↗ Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir Unknown status Laboratorios Goulart S.A. Phase 3 2010-05-01 To measure the efficacy of Taro Elixir compare with Oxytetracycline in the treatment of boils or acne.
NCT02017197 ↗ Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil Completed Fundação de Amparo à Pesquisa do Estado de São Paulo Phase 4 2014-08-01 The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for oxytetracycline

Condition Name

Condition Name for oxytetracycline
Intervention Trials
Acne Vulgaris II or III Degree 1
Atrial Fibrillation 1
Boils 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for oxytetracycline
Intervention Trials
Atrial Fibrillation 1
Wound Infection 1
Acne Vulgaris 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for oxytetracycline

Trials by Country

Trials by Country for oxytetracycline
Location Trials
Brazil 3
United States 2
Norway 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for oxytetracycline
Location Trials
Kentucky 1
Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for oxytetracycline

Clinical Trial Phase

Clinical Trial Phase for oxytetracycline
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for oxytetracycline
Clinical Trial Phase Trials
Completed 3
Unknown status 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for oxytetracycline

Sponsor Name

Sponsor Name for oxytetracycline
Sponsor Trials
University of Virginia 1
Laboratorios Goulart S.A. 1
Fundação de Amparo à Pesquisa do Estado de São Paulo 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for oxytetracycline
Sponsor Trials
Other 7
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.